(NASDAQ: NUWE) Nuwellis's forecast annual revenue growth rate of 63.34% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.49%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.96%.
Nuwellis's revenue in 2026 is $8,769,000.On average, 3 Wall Street analysts forecast NUWE's revenue for 2026 to be $770,909, with the lowest NUWE revenue forecast at $740,731, and the highest NUWE revenue forecast at $793,580. On average, 3 Wall Street analysts forecast NUWE's revenue for 2027 to be $863,509, with the lowest NUWE revenue forecast at $829,655, and the highest NUWE revenue forecast at $888,938.
In 2028, NUWE is forecast to generate $3,320,843 in revenue, with the lowest revenue forecast at $3,190,635 and the highest revenue forecast at $3,418,499.